Clinical Trial

A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension

Name: A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension — clinical trial record (NCT07758634)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

A Study of CTX340 in Participants with Uncontrolled Hypertension.

Trial Details

NCT Number	NCT07758634
Lead Sponsor	CRISPR Therapeutics AG
Conditions	Hypertension
Enrollment	69 participants
Start Date	2026-08-08
Primary Completion	2028-07-01 (estimated)
Study Completion	2029-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-11